Latest News & Updates

Breaking News

  • 23 hours ago

  • Vaibhavi M.

Medera Gains DMC Clearance to Advance SRD-002 HFpEF Gene Therapy Into Randomized Phase
Breaking News
ImmuPharma Appoints Bachem as API Manufacturing Partner for Kapiglucagon Glucagon Prodrug Program

Vaibhavi M.

Other trending news you may like to read

Medera Gains DMC Clearance to Advance SRD-002 HFpEF Gene Therapy Into Randomized Phase

Medera's DMC clears MUSIC-HFpEF trial to advance without protocol changes, opening the path to FDA discussions on the next randomized stage.

Vaibhavi M.

Pharma Now

ImmuPharma Appoints Bachem as API Manufacturing Partner for Kapiglucagon Glucagon Prodrug Program

ImmuPharma selects Bachem AG as API manufacturing partner for Kapiglucagon, marking a key CMC milestone ahead of IND-enabling activities.

Vaibhavi M.

Pharma Now

ProQR Achieves First Clinical Validation of Axiomer RNA Editing Platform in Phase 1 AX-0810 Study

ProQR's Phase 1 AX-0810 data confirm first clinical validation of the Axiomer RNA editing platform, with dose-dependent NTCP target engagement.

Vaibhavi M.

Pharma Now

Intas Pharmaceuticals Appoints Girish Bhunje as Senior Vice President of API Operations

Intas Pharmaceuticals names Girish Bhunje SVP – API Operations, reinforcing executive-level GMP and supply chain leadership.

Vaibhavi M.

Pharma Now